(Botox) Mechanisms of Action in Altering the Molecular Environment in Which Pain Fibers Exist
Status:
Unknown status
Trial end date:
2020-08-01
Target enrollment:
Participant gender:
Summary
To compare Botox-treated and Botox-untreated symptomatic tissues (defined as areas where the
head hurts and the pain is felt) of chronic migraine (CM) patients using molecular studies.
Phase:
Phase 4
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
Beth Israel Deaconess Medical Center
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A